ABOUT US  |  CONTACT US  |  RSS  |  ARCHIVE  |  2020-09-18  |  UPDATED: 1399/06/28 - 17:38:3 FA | AR | EN
Qamishli residents call for removal of US, Turkish occupation forces from Syria            South Africa says Ďsurprisedí by Ďbizarreí report of Iran plot to kill US envoy            President Maduro: EU demand to delay election in Venezuela íimpossibleí            UAE cracking down hard on anti-Israel sentiment with 10-year prison sentences: Dissident            India building tunnel in Himalayas to get soldiers to Chinese border in 10 minutes             FBI warns of ícombustible violenceí on US streets ahead of November election             Trumpís Former NSA says withdrawal of US troops from Afghanistan is an unwise policy             US Embassy warns of extremist attacks against women            Afghanistan, Tajikistan discuss Afghan peace, bilateral trade and economic ties            Asian, European markets sink after US Fed warning of íuncertainí outlook            China files formal complaint with US over senior official visiting Taiwan            Can US Electoral College survive another disputed election?             Top aides to Pompeo grilled at Congress over US arms sales to Saudi Arabia             Gunmen fire 55 shots, killing at least two in Philadelphia            UAE, Bahrain activists highlight public resentment of deals with Israel            


DATE PUBLISHED: 1399/06/26 - 17:15:5
VISIT: 178
SHARE WITH YOUR FRIENDS

Russia to sell 100mn doses of COVID-19 vaccine to India


Russia reportedly reaches a deal to sell its coronavirus vaccine to India. (File photo)

Russiaís sovereign wealth fund has reportedly reached a deal to sell 100 million doses of its COVID-19 vaccine, called Sputnik-V, to a major pharmaceutical company in India.

Clinical trials of the Russian vaccine in India are expected to follow and to be held jointly with the company, said a source close to the deal on Wednesday as cited in a Reuters report, which further noted that both the trials and supply deal depend on domestic regulatory approval.

According to the report, the Russian Direct Investment Fund (RDIF) has so far signed vaccine supply deals with Kazakhstan, Brazil and Mexico and has reached a manufacturing partnership agreement with India to produce 300 million doses of the Sputnik-V vaccine there.

The source also noted that RDIF will announce the name of the Indian company later on Wednesday.

Russia introduced Sputnik-V as the first vaccine against coronavirus to be registered in the world. Large-scale trials, known as Phase III trials, involving at least 40,000 people were launched in Russia on August 26.

Positive results in China-UAE phase 3 COVID-19 vaccine trials

This is while Chinese Foreign Ministry spokesman Wang Wenbin also declared during a Wednesday press briefing in Beijing that China and the United Arab Emirates (UAE) have seen some positive results in their Phase III COVID-19 vaccine trials, Chi.

The UAE granted emergency approval for the use of a coronavirus vaccine on Monday, six weeks after human trials in the Persian Gulf Arab state was first launched.

Pfizer COVID-19 vaccine trial reports no major safety issues

Meanwhile, researchers monitoring Pfizer Inc.ís giant trial of an experimental COVID-19 vaccine have reported no safety problems even after more than 12,000 people received their second of two doses, Bloomberg reported Wednesday.

"So far there has been no safety signal reported," said Mikael Dolsten, Pfizerís chief scientific officer, in an online meeting with investors.

The trial, now targeted at enrolling 44,000 people, has reached its initial goal of 30,000 subjects, Pfizer executives added. The drug makers have expanded the trial to allow inclusion of teenagers and people with certain medical conditions, like HIV.

The trial compares two shots of the vaccine Pfizer is co-developing with Germanyís BioNTech SE to two doses of a placebo. While the doctors and subjects in the trial donít know who got the vaccine - a measure to avoid bias - a committee of outside experts that knows which people received the shot is reviewing safety data on a weekly basis, Pfizer executives said during the investor meeting.

"They would notify us if they had any safety concerns and have not done that to date," Kathrin Jansen, Pfizerís head of vaccine research, said during the meeting. The companyís own scientists are also looking for worrisome adverse events that havenít appeared so far. Fatigue has been the most common side effect seen in the trial thus far, according to the Pfizer presentation.

Pfizer confirmed it expects to get conclusive data on the vaccineís efficacy by the end of October. The board monitoring the trial will conduct its first review of the data for efficacy when a total of 32 coronavirus cases have been seen among participants, Pfizer executives said during the investor meeting.

The company promised to make all its safety and efficacy data publicly available should it seek emergency authorization for the vaccine.

"What we are doing in terms of releasing data is very unusual," Chief Executive Officer Albert Bourla said on a call with the press, citing ongoing conversations with US regulators and Congress. "It is a must to release this data."

Potential nasal spray COVID-19 vaccine in China clinical trial

Moreover, China has also begun human trials of a nasal spray COVID-19 candidate vaccine that could serve as an alternative to injections.

The vaccine has become the first of its kind in the world to proceed to the clinical trial phase, according to the WHOís list of candidate vaccines released last Wednesday.

Scientists hope that the vaccine puffed into the nose could be effective in preventing the coronavirus, which spreads through the respiratory tract.

It could be delivered along with an injected vaccine to mount a multi-pronged approach.

Another advantage of the nasal spray vaccine is that it can be easily self-administered.

The vaccine has been co-developed by HKU, Fujian Provinceís Xiamen University, and vaccine-maker Beijing Wantai Biological Pharmacy Enterprise Co. Ltd.

Germany: Coronavirus vaccine likely available by mid-2021

The German government is also expecting to make available a COVID-19 vaccine for parts of its population early next year, with three firms due to be subsidized by the government to research potential vaccines.

German Health Minister Jens Spahn and Research Minister Anja Karliczek announced during a Berlin press briefing on Tuesday that they expected a COVID-19 vaccine to be ready next year, adding that research by three German companies - BioNTech, CureVac, and IDT Biologika - was currently being funded.

But the ministers both warned that "risky shortcuts" would not be taken, that a vaccine would not be available to most the population until the middle of next year. "We want a safe and effective vaccine, not necessarily to be the first," Spahn said.

"Safety has absolute priority on this point," Karliczek added.

 

LINK: https://www.ansarpress.com/english/20281


TAGS:






*
*

*



SEE ALSO

Hurricane Sally swamps US Gulf Coast with massive floods, íunrealí rain


Germany to take in 1,500 more Lesbos island migrants


India coronavirus cases cross 5 million in Ďworse-than-sci-fií pandemic


13 detained after fire near second Greek refugee camp


Thousands of Oregon evacuees shelter from wildfires as US disaster declared


Six Afghan refugees suspected of having set fire to Moria camp


40 New COVID-19 Cases Reported in Afghanistan: Ministry


Drone shows sprawling new tent camp for Lesbos migrants


COVID-19 hits Afghan children hard, deprives millions of an education


World wildlife plummets more than two-thirds in 50 years: Index





VIEWED
MOST DISCUSSED




POLL

Modi, Merkel Discuss Afghanistan, Radicalisation And Terrorism

SEE RESULT


LAST NEWS

EU parliament urges arms embargo on Saudi Arabia over Khashoggi murder, Yemen war

Qamishli residents call for removal of US, Turkish occupation forces from Syria

South Africa says Ďsurprisedí by Ďbizarreí report of Iran plot to kill US envoy

President Maduro: EU demand to delay election in Venezuela íimpossibleí

UAE cracking down hard on anti-Israel sentiment with 10-year prison sentences: Dissident

India building tunnel in Himalayas to get soldiers to Chinese border in 10 minutes

FBI warns of ícombustible violenceí on US streets ahead of November election

Trumpís Former NSA says withdrawal of US troops from Afghanistan is an unwise policy

US Embassy warns of extremist attacks against women

Afghanistan, Tajikistan discuss Afghan peace, bilateral trade and economic ties

Asian, European markets sink after US Fed warning of íuncertainí outlook

China files formal complaint with US over senior official visiting Taiwan

Can US Electoral College survive another disputed election?

Top aides to Pompeo grilled at Congress over US arms sales to Saudi Arabia

Gunmen fire 55 shots, killing at least two in Philadelphia

UAE, Bahrain activists highlight public resentment of deals with Israel

Mexico asks US for info about reported abuse of migrants, hysterectomies

Venezuela blasts UN rights report as Ďriddled with falsehoodsí

Hurricane Sally swamps US Gulf Coast with massive floods, íunrealí rain

Palestinian resistance groups know no red lines in war with Israel: Islamic Jihad leader

US attorney general calls for sedition charges against anti-racism protesters

Libyaís Prime Minister Sarraj says will resign by end of next month

After failure at UN, US says will work to hinder arms trades with Iran with its own action

Biden, Trump trade barbs over vaccine as US pres. contradicts top experts

Turkey Ďopen to constructive dialogí with Greece in maritime dispute

Germany to take in 1,500 more Lesbos island migrants

No Ceasefire Until Cause of War is Discussed: Taliban Spokesman

Foreign Minister to Discuss Trade and Transit Development with Tajikistan

India coronavirus cases cross 5 million in Ďworse-than-sci-fií pandemic

Iran sees a big change in mining with gold prospecting

Russia to sell 100mn doses of COVID-19 vaccine to India

Rouhani congratulates Iranians on assured victory against US over sanctions snapback

ICE nurse raises alarm over medical care at detention center; Pelosi demands probe

UN war crimes panel urges Turkey to rein in allied militants in N Syria

13 detained after fire near second Greek refugee camp

Myanmar army admits to Ďpossible wider patternsí of violence against Rohingya

Turkey complains Greece militarizing Chios; extends drilling activity off Cyprus

Japanís lower house of parliament elects Yoshihide Suga as prime minister

Thousands of Oregon evacuees shelter from wildfires as US disaster declared

Iran complains to UN over Trumpís military threat, stresses right to self-defense


MEDICAL NEWS


ANSAR PRESS ©  |  ABOUT US  |  CONTACT US  |  MOBILE VERSION  |  LINKS  |  DESIGN: Negah Network Co.
All right reserved. Use this website by mentioning the source (link) is allowed. ›—ś‘ź«Ś «یš —š ی šŕŠ»šŌ«š